— Know what they know.
Not Investment Advice

WPHM OTC

Winston Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -66.7% 1Y: -66.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $7741 mcap · 77M float · 0.020% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.000300000014
Volume16,186
Avg Volume15,107
Beta-982.38
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoel E. Bernstein
Employees9
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2023-06-05
100 North Fairway Drive
Vernon Hills, IL 60061
US
+1 847 362 8200
About Winston Pharmaceuticals, Inc.

Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis. They also tackle pain and inflammation linked to inflammatory bowel disease, alongside other specialized therapeutic areas. The organization, initially established as Winston Laboratories, Inc., adopted its present name, Winston Pharmaceuticals, Inc., in November 2008. Founded in 1998, Winston Pharmaceuticals maintains its principal operations in Vernon Hills, Illinois.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
FROST PHILLIP MD ET S-Sale 1,741 $0.35 2009-12-16
HALPRYN GLENN L C-Conversion 229,000 $0.00 2009-09-24
HALPRYN GLENN L C-Conversion 229 — 2009-09-24
FROST PHILLIP MD ET C-Conversion 4,583,000 $0.00 2009-09-24
FROST PHILLIP MD ET C-Conversion 12,476,000 $0.00 2009-09-24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms